Subclavian artery stenting: Immediate and mid term clinical follow-up results

I. Sheiban, A. Dharmadhikari, G. Melissano, V. Tzifos, M. Montorfano, F. Leonardo, C. Di Mario, R. Chiesa, A. Colombo

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Intravascular stents are increasingly being used to treat subclavian artery obstructive disease. This study aimed to assess the immediate and midterm clinical outcome of subclavian artery stenting. METHODS AND RESULTS: Total occlusion of the subclavian artery was seen in 7 (28%) out of the 25 consecutive patients treated for subclavican artery stenosis. Mean lesion length was 14±4.3 mm. The mean preprocedure diameter stenosis was reduced from 83.2±14.9% to 9.6±5.4% postprocedure. Procedural success was achieved in all patients. Clinical follow-up was obtained in all patients. The initial success was maintained at follow-up (mean=12±4 months) in 24 (96%) patients. Recurrence of symptoms occurred in 1 (4%) patient who had an angiographically documented restenosis four months after the procedure. It was successfully redilated. CONCLUSION: Stenting for subclavian artery obstructive disease is safe, technically feasible and has favorable clinical outcomes. It may be considered as the therapy of choice for subclavian artery obstructive disease.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalInternational Journal of Cardiovascular Interventions
Volume3
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Subclavian Artery
Pathologic Constriction
Stents
Arteries
Recurrence

Keywords

  • Angioplasty
  • Endoluminal therapeutics
  • Stents
  • Subclavian artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Subclavian artery stenting : Immediate and mid term clinical follow-up results. / Sheiban, I.; Dharmadhikari, A.; Melissano, G.; Tzifos, V.; Montorfano, M.; Leonardo, F.; Di Mario, C.; Chiesa, R.; Colombo, A.

In: International Journal of Cardiovascular Interventions, Vol. 3, No. 4, 2000, p. 231-235.

Research output: Contribution to journalArticle

Sheiban, I. ; Dharmadhikari, A. ; Melissano, G. ; Tzifos, V. ; Montorfano, M. ; Leonardo, F. ; Di Mario, C. ; Chiesa, R. ; Colombo, A. / Subclavian artery stenting : Immediate and mid term clinical follow-up results. In: International Journal of Cardiovascular Interventions. 2000 ; Vol. 3, No. 4. pp. 231-235.
@article{e2c669044dc34718ab1ac339d2f048a1,
title = "Subclavian artery stenting: Immediate and mid term clinical follow-up results",
abstract = "BACKGROUND: Intravascular stents are increasingly being used to treat subclavian artery obstructive disease. This study aimed to assess the immediate and midterm clinical outcome of subclavian artery stenting. METHODS AND RESULTS: Total occlusion of the subclavian artery was seen in 7 (28{\%}) out of the 25 consecutive patients treated for subclavican artery stenosis. Mean lesion length was 14±4.3 mm. The mean preprocedure diameter stenosis was reduced from 83.2±14.9{\%} to 9.6±5.4{\%} postprocedure. Procedural success was achieved in all patients. Clinical follow-up was obtained in all patients. The initial success was maintained at follow-up (mean=12±4 months) in 24 (96{\%}) patients. Recurrence of symptoms occurred in 1 (4{\%}) patient who had an angiographically documented restenosis four months after the procedure. It was successfully redilated. CONCLUSION: Stenting for subclavian artery obstructive disease is safe, technically feasible and has favorable clinical outcomes. It may be considered as the therapy of choice for subclavian artery obstructive disease.",
keywords = "Angioplasty, Endoluminal therapeutics, Stents, Subclavian artery disease",
author = "I. Sheiban and A. Dharmadhikari and G. Melissano and V. Tzifos and M. Montorfano and F. Leonardo and {Di Mario}, C. and R. Chiesa and A. Colombo",
year = "2000",
doi = "10.1080/14628840050515984",
language = "English",
volume = "3",
pages = "231--235",
journal = "International Journal of Cardiovascular Interventions",
issn = "1462-8848",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Subclavian artery stenting

T2 - Immediate and mid term clinical follow-up results

AU - Sheiban, I.

AU - Dharmadhikari, A.

AU - Melissano, G.

AU - Tzifos, V.

AU - Montorfano, M.

AU - Leonardo, F.

AU - Di Mario, C.

AU - Chiesa, R.

AU - Colombo, A.

PY - 2000

Y1 - 2000

N2 - BACKGROUND: Intravascular stents are increasingly being used to treat subclavian artery obstructive disease. This study aimed to assess the immediate and midterm clinical outcome of subclavian artery stenting. METHODS AND RESULTS: Total occlusion of the subclavian artery was seen in 7 (28%) out of the 25 consecutive patients treated for subclavican artery stenosis. Mean lesion length was 14±4.3 mm. The mean preprocedure diameter stenosis was reduced from 83.2±14.9% to 9.6±5.4% postprocedure. Procedural success was achieved in all patients. Clinical follow-up was obtained in all patients. The initial success was maintained at follow-up (mean=12±4 months) in 24 (96%) patients. Recurrence of symptoms occurred in 1 (4%) patient who had an angiographically documented restenosis four months after the procedure. It was successfully redilated. CONCLUSION: Stenting for subclavian artery obstructive disease is safe, technically feasible and has favorable clinical outcomes. It may be considered as the therapy of choice for subclavian artery obstructive disease.

AB - BACKGROUND: Intravascular stents are increasingly being used to treat subclavian artery obstructive disease. This study aimed to assess the immediate and midterm clinical outcome of subclavian artery stenting. METHODS AND RESULTS: Total occlusion of the subclavian artery was seen in 7 (28%) out of the 25 consecutive patients treated for subclavican artery stenosis. Mean lesion length was 14±4.3 mm. The mean preprocedure diameter stenosis was reduced from 83.2±14.9% to 9.6±5.4% postprocedure. Procedural success was achieved in all patients. Clinical follow-up was obtained in all patients. The initial success was maintained at follow-up (mean=12±4 months) in 24 (96%) patients. Recurrence of symptoms occurred in 1 (4%) patient who had an angiographically documented restenosis four months after the procedure. It was successfully redilated. CONCLUSION: Stenting for subclavian artery obstructive disease is safe, technically feasible and has favorable clinical outcomes. It may be considered as the therapy of choice for subclavian artery obstructive disease.

KW - Angioplasty

KW - Endoluminal therapeutics

KW - Stents

KW - Subclavian artery disease

UR - http://www.scopus.com/inward/record.url?scp=0034500524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034500524&partnerID=8YFLogxK

U2 - 10.1080/14628840050515984

DO - 10.1080/14628840050515984

M3 - Article

AN - SCOPUS:0034500524

VL - 3

SP - 231

EP - 235

JO - International Journal of Cardiovascular Interventions

JF - International Journal of Cardiovascular Interventions

SN - 1462-8848

IS - 4

ER -